NCT03528694 2026-04-14
POTOMAC
AstraZeneca
Phase 3 Active not recruiting
AstraZeneca
Janssen Research & Development, LLC
Oslo University Hospital
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
ImmunityBio, Inc.